| Primary |
| Product Used For Unknown Indication |
43.5% |
| Hypertension |
19.5% |
| Atrial Fibrillation |
6.8% |
| Drug Use For Unknown Indication |
3.8% |
| Pain |
3.2% |
| Myocardial Infarction |
2.9% |
| Coronary Artery Disease |
2.8% |
| Cardiac Disorder |
2.2% |
| Blood Pressure |
1.9% |
| Cardiac Failure |
1.8% |
| Type 2 Diabetes Mellitus |
1.6% |
| Depression |
1.5% |
| Osteoporosis |
1.4% |
| Cardiac Failure Chronic |
1.1% |
| Prophylaxis |
1.1% |
| Diabetes Mellitus |
1.0% |
| Hypercholesterolaemia |
1.0% |
| Hyperlipidaemia |
1.0% |
| Acute Myocardial Infarction |
0.9% |
| Arrhythmia Supraventricular |
0.9% |
|
| Syncope |
17.2% |
| Renal Failure Acute |
7.5% |
| Drug Interaction |
6.7% |
| Small For Dates Baby |
6.7% |
| Tremor |
6.0% |
| Ventricular Tachycardia |
6.0% |
| Somnolence |
5.2% |
| Toxicity To Various Agents |
4.5% |
| Bradyarrhythmia |
3.7% |
| Nightmare |
3.7% |
| Tachycardia |
3.7% |
| Transient Ischaemic Attack |
3.7% |
| Vertigo |
3.7% |
| Weight Increased |
3.7% |
| Abscess |
3.0% |
| Fatigue |
3.0% |
| Product Substitution Issue |
3.0% |
| Sedation |
3.0% |
| Sinus Bradycardia |
3.0% |
| Suicide Attempt |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
33.0% |
| Hypertension |
19.1% |
| Drug Use For Unknown Indication |
8.8% |
| Drug Abuse |
7.4% |
| Atrial Fibrillation |
5.3% |
| Depression |
3.5% |
| Coronary Artery Disease |
2.7% |
| Type 2 Diabetes Mellitus |
2.4% |
| Cardiac Failure |
2.3% |
| Pain |
2.0% |
| Intentional Overdose |
1.7% |
| Ventricular Tachycardia |
1.7% |
| Myocardial Infarction |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Hypercholesterolaemia |
1.4% |
| Suicide Attempt |
1.2% |
| Acute Myocardial Infarction |
1.2% |
| Cardiac Failure Chronic |
1.1% |
| Left Ventricular Dysfunction |
1.1% |
| Cardiac Murmur |
1.0% |
|
| Syncope |
18.2% |
| Ventricular Tachycardia |
14.8% |
| Renal Failure Acute |
9.1% |
| Vomiting |
5.7% |
| Suicide Attempt |
5.0% |
| Thrombocytopenia |
4.7% |
| Somnolence |
4.4% |
| Bradycardia |
3.8% |
| Paraesthesia |
3.8% |
| Weight Loss Poor |
3.8% |
| Hypotension |
3.5% |
| Drug Interaction |
2.8% |
| Palpitations |
2.8% |
| Transient Ischaemic Attack |
2.8% |
| Unresponsive To Stimuli |
2.8% |
| Vision Blurred |
2.8% |
| Shock |
2.5% |
| Angioedema |
2.2% |
| Hyponatraemia |
2.2% |
| Panic Attack |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.2% |
| Hypertension |
16.7% |
| Drug Use For Unknown Indication |
14.3% |
| Atrial Fibrillation |
5.4% |
| Rheumatoid Arthritis |
4.4% |
| Cardiac Failure |
2.9% |
| Prophylaxis |
2.7% |
| Pain |
2.6% |
| Diabetes Mellitus |
2.5% |
| Coronary Artery Disease |
2.5% |
| Hypercholesterolaemia |
1.9% |
| Type 2 Diabetes Mellitus |
1.8% |
| Depression |
1.7% |
| Osteoporosis |
1.3% |
| Myocardial Infarction |
1.3% |
| Myocardial Ischaemia |
1.2% |
| Breast Cancer |
1.2% |
| Cardiac Disorder |
1.2% |
| Acute Coronary Syndrome |
1.1% |
| Blood Cholesterol Increased |
1.0% |
|
| Vomiting |
12.7% |
| Renal Failure Acute |
10.0% |
| Renal Failure |
7.8% |
| Rhabdomyolysis |
6.4% |
| Thrombocytopenia |
5.8% |
| Myocardial Infarction |
5.8% |
| Pneumonia |
5.5% |
| Weight Decreased |
5.4% |
| Syncope |
4.5% |
| Urinary Tract Infection |
4.0% |
| Sepsis |
3.8% |
| Weight Increased |
3.5% |
| International Normalised Ratio Increased |
3.4% |
| Atrial Fibrillation |
3.3% |
| Death |
3.1% |
| Pyrexia |
3.1% |
| Drug Interaction |
3.1% |
| Nausea |
2.9% |
| Tremor |
2.8% |
| Ventricular Tachycardia |
2.8% |
|
| Interacting |
| Hypertension |
38.7% |
| Product Used For Unknown Indication |
7.5% |
| Drug Use For Unknown Indication |
7.0% |
| Type 2 Diabetes Mellitus |
6.5% |
| Myocardial Infarction |
6.0% |
| Coronary Artery Disease |
5.7% |
| Depression |
5.7% |
| Hyperlipidaemia |
5.2% |
| Duodenal Ulcer |
2.6% |
| Atrial Fibrillation |
1.8% |
| Bundle Branch Block Left |
1.6% |
| Dementia |
1.6% |
| Dementia Alzheimer's Type |
1.6% |
| Ischaemic Cardiomyopathy |
1.6% |
| Pain |
1.6% |
| Renal Failure |
1.3% |
| Blood Pressure Increased |
1.0% |
| Cardiac Failure |
1.0% |
| Cognitive Disorder |
1.0% |
| Ischaemic Heart Disease Prophylaxis |
1.0% |
|
| Drug Interaction |
22.7% |
| Syncope |
18.7% |
| Hypotension |
9.3% |
| Renal Failure Acute |
6.7% |
| Sedation |
5.3% |
| Headache |
4.0% |
| Rhabdomyolysis |
4.0% |
| Throat Irritation |
4.0% |
| Dehydration |
2.7% |
| Hypoglycaemia |
2.7% |
| International Normalised Ratio Increased |
2.7% |
| Nausea |
2.7% |
| Torsade De Pointes |
2.7% |
| Urinary Tract Obstruction |
2.7% |
| Vertigo |
2.7% |
| Heart Rate Irregular |
1.3% |
| Hyperkalaemia |
1.3% |
| Medication Error |
1.3% |
| Off Label Use |
1.3% |
| Overdose |
1.3% |
|
